# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Lodoxamide | Lodoxamide | HepSE_cirrhosis | = | 0 | ALA1909310 | ||||||
2. | Lodoxamide | Lodoxamide | HepSE_cholelithiasis | = | 0 | ALA1909309 | ||||||
3. | Lodoxamide | Lodoxamide | HepSE_cholecystitis | = | 0 | ALA1909308 | ||||||
4. | Lodoxamide | Lodoxamide | HepSE_bilirubinemia | = | 0 | ALA1909307 | ||||||
5. | D,L-Venlafaxine | Venlafaxine | HepSE_Combined Scores | = | 7 | ALA1909320 | ||||||
6. | D,L-Venlafaxine | Venlafaxine | HepSE_liver function tests abnormal | = | 0 | ALA1909319 | ||||||
7. | D,L-Venlafaxine | Venlafaxine | HepSE_liver fatty | = | 1 | ALA1909318 | ||||||
8. | D,L-Venlafaxine | Venlafaxine | HepSE_liver disease | = | 0 | ALA1909317 | ||||||
9. | D,L-Venlafaxine | Venlafaxine | HepSE_jaundice | = | 1 | ALA1909316 | ||||||
10. | D,L-Venlafaxine | Venlafaxine | HepSE_hepatomegaly | = | 0 | ALA1909315 | ||||||
11. | D,L-Venlafaxine | Venlafaxine | HepSE_hepatitis | = | 1 | ALA1909314 | ||||||
12. | D,L-Venlafaxine | Venlafaxine | HepSE_hepatic necrosis | = | 0 | ALA1909313 | ||||||
13. | D,L-Venlafaxine | Venlafaxine | HepSE_hepatic failure | = | 0 | ALA1909312 | ||||||
14. | D,L-Venlafaxine | Venlafaxine | HepSE_elevated liver function tests | = | 0 | ALA1909311 | ||||||
15. | D,L-Venlafaxine | Venlafaxine | HepSE_cirrhosis | = | 1 | ALA1909310 | ||||||
16. | D,L-Venlafaxine | Venlafaxine | HepSE_cholelithiasis | = | 1 | ALA1909309 | ||||||
17. | D,L-Venlafaxine | Venlafaxine | HepSE_cholecystitis | = | 1 | ALA1909308 | ||||||
18. | D,L-Venlafaxine | Venlafaxine | HepSE_bilirubinemia | = | 1 | ALA1909307 | ||||||
19. | Capecitabine | Capecitabine | HepSE_Combined Scores | = | 7 | ALA1909320 | ||||||
20. | Capecitabine | Capecitabine | HepSE_liver function tests abnormal | = | 1 | ALA1909319 |